{
    "organizations": [],
    "uuid": "3dc66ccd657cefff813e8ce385df2663a926ed62",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tmunity-therapeutics-raises-100-ml/brief-tmunity-therapeutics-raises-100-mln-in-series-a-financing-to-advance-portfolio-of-t-cell-immunotherapies-idUSASB0C1VC",
    "ord_in_thread": 0,
    "title": "BRIEF-Tmunity Therapeutics Raises $100 Mln In Series A Financing To Advance Portfolio Of T Cell Immunotherapies",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 23 (Reuters) -\n* TMUNITY THERAPEUTICS RAISES $100 MILLION IN SERIES A FINANCING TO ADVANCE PORTFOLIO OF NEXT-GENERATION T CELL IMMUNOTHERAPIES TO TRANSFORM THE TREATMENT OF CANCER\n* TMUNITY THERAPEUTICS - RAISES $100 MILLION IN SERIES A FINANCING, INVESTORS INCLUDE PING AN VENTURES, GILEAD SCIENCES INC, LILLY ASIA VENTURESâ€‹, OTHERS Source text for Eikon:\n ",
    "published": "2018-01-23T21:24:00.000+02:00",
    "crawled": "2018-01-24T15:48:43.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "tmunity",
        "therapeutic",
        "raise",
        "million",
        "series",
        "financing",
        "advance",
        "portfolio",
        "cell",
        "immunotherapy",
        "transform",
        "treatment",
        "cancer",
        "tmunity",
        "therapeutic",
        "raise",
        "million",
        "series",
        "financing",
        "investor",
        "include",
        "ping",
        "venture",
        "gilead",
        "science",
        "inc",
        "lilly",
        "asia",
        "others",
        "source",
        "text",
        "eikon"
    ]
}